Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Olympus Pays Record Anti-Kickback Penalty For Device Case

This article was originally published in Clinica

Executive Summary

Olympus Corp. is making a record payment and implementing stricter internal compliance controls and monitoring to avoid prosecution on kickback allegations.

You may also be interested in...



Unlocking Legalities: False-Claim Standards Continue To Evolve

The finer points of when exactly the US government can collect from a device company for selling it a bill of goods are under reconsideration, even as the fast pace of False Claims Act suits continues, attorneys with law firm Gibson Dunn concluded during a series of recent webinars.

Medtech And US DoJ: A Snapshot Of 2016 Pay-Outs And Pleas

The US Department of Justice has announced resolution of 14 device-related investigations in 2016, including settlements, guilty pleas and a few executive convictions. The largest settlement this year, with Olympus Corp., accounted for almost three-quarters of the $825.5m total value of medtech fines in 2016.

US Health-Care Enforcement Focus Continues To Expand, Officials Say

Reimbursement efforts, individual liability and innovative corporate integrity agreements were among areas of focus at a recent Food and Drug Institute enforcement forum.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT103248

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel